Inovio Pharmaceuticals (INO) Stock: Running For The Top On Clinical Data
Inovio Pharmaceuticals Inc (NASDAQ: INO) is having an overwhelmingly strong start to the trading session in the pre-market hours after releasing new clinical data. The data came from the company’s PENNVAX®-GP, an HIV vaccine that’s showing some promising results. Of course, the clinical update led to excitement among investors, sending the stock on a run for … Read more